BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11456499)

  • 1. 19F NMR of trifluoroacetyl-labeled cysteine mutants of myoglobin: structural probes of nitric oxide bound to the H93G cavity mutant.
    Thomas MR; Boxer SG
    Biochemistry; 2001 Jul; 40(29):8588-96. PubMed ID: 11456499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A photolysis-triggered heme ligand switch in H93G myoglobin.
    Franzen S; Bailey J; Dyer RB; Woodruff WH; Hu RB; Thomas MR; Boxer SG
    Biochemistry; 2001 May; 40(17):5299-305. PubMed ID: 11318654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen bonding modulates binding of exogenous ligands in a myoglobin proximal cavity mutant.
    Decatur SM; Belcher KL; Rickert PK; Franzen S; Boxer SG
    Biochemistry; 1999 Aug; 38(34):11086-92. PubMed ID: 10460164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTIR and resonance Raman studies of nitric oxide binding to H93G cavity mutants of myoglobin.
    Thomas MR; Brown D; Franzen S; Boxer SG
    Biochemistry; 2001 Dec; 40(49):15047-56. PubMed ID: 11732927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans effects in nitric oxide binding to myoglobin cavity mutant H93G.
    Decatur SM; Franzen S; DePillis GD; Dyer RB; Woodruff WH; Boxer SG
    Biochemistry; 1996 Apr; 35(15):4939-44. PubMed ID: 8664286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of protein function by exogenous ligands in protein cavities: CO binding to a myoglobin cavity mutant containing unnatural proximal ligands.
    Decatur SM; DePillis GD; Boxer SG
    Biochemistry; 1996 Apr; 35(13):3925-32. PubMed ID: 8672423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of thiolate- and carboxylate-ligated ferric H93G myoglobin: models for cytochrome P450 and for oxyanion-bound heme proteins.
    Qin J; Perera R; Lovelace LL; Dawson JH; Lebioda L
    Biochemistry; 2006 Mar; 45(10):3170-7. PubMed ID: 16519512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximal ligand control of heme iron coordination structure and reactivity with hydrogen peroxide: investigations of the myoglobin cavity mutant H93G with unnatural oxygen donor proximal ligands.
    Roach MP; Puspita WJ; Watanabe Y
    J Inorg Biochem; 2000 Aug; 81(3):173-82. PubMed ID: 11051562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1H NMR characterization of myoglobins where exogenous ligands replace the proximal histidine.
    Decatur SM; Boxer SG
    Biochemistry; 1995 Feb; 34(7):2122-9. PubMed ID: 7857922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of photolysis and rebinding kinetics in myoglobin using proximal ligand replacements.
    Cao W; Ye X; Sjodin T; Christian JF; Demidov AA; Berezhna S; Wang W; Barrick D; Sage JT; Champion PM
    Biochemistry; 2004 Aug; 43(34):11109-17. PubMed ID: 15323570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations of the myoglobin cavity mutant H93G with unnatural imidazole proximal ligands as a modular peroxide O-O bond cleavage model system.
    Roach MP; Ozaki S; Watanabe Y
    Biochemistry; 2000 Feb; 39(6):1446-54. PubMed ID: 10684626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H93G myoglobin cavity mutant as a versatile template for modeling heme proteins: ferrous, ferric, and ferryl mixed-ligand complexes with imidazole in the cavity.
    Pond AE; Roach MP; Thomas MR; Boxer SG; Dawson JH
    Inorg Chem; 2000 Dec; 39(26):6061-6. PubMed ID: 11151505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assignment of the heme axial ligand(s) for the ferric myoglobin (H93G) and heme oxygenase (H25A) cavity mutants as oxygen donors using magnetic circular dichroism.
    Pond AE; Roach MP; Sono M; Rux AH; Franzen S; Hu R; Thomas MR; Wilks A; Dou Y; Ikeda-Saito M; Ortiz de Montellano PR; Woodruff WH; Boxer SG; Dawson JH
    Biochemistry; 1999 Jun; 38(23):7601-8. PubMed ID: 10360958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal ligand motions in H93G myoglobin.
    Franzen S; Peterson ES; Brown D; Friedman JM; Thomas MR; Boxer SG
    Eur J Biochem; 2002 Oct; 269(19):4879-86. PubMed ID: 12354119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of heme iron coordination and protein structure in the dynamics and geminate rebinding of nitric oxide to the H93G myoglobin mutant: implications for nitric oxide sensors.
    Negrerie M; Kruglik SG; Lambry JC; Vos MH; Martin JL; Franzen S
    J Biol Chem; 2006 Apr; 281(15):10389-98. PubMed ID: 16476730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inversion of axial coordination in myoglobin to create a "proximal" ligand binding pocket.
    Uno T; Sakamoto R; Tomisugi Y; Ishikawa Y; Wilkinson AJ
    Biochemistry; 2003 Sep; 42(34):10191-9. PubMed ID: 12939147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of proximal side mutations on the molecular and electronic structure of cyanomet myoglobin: an 1H NMR study.
    Wu Y; Chien EY; Sligar SG; La Mar GN
    Biochemistry; 1998 May; 37(19):6979-90. PubMed ID: 9578585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement of the proximal ligand of sperm whale myoglobin with free imidazole in the mutant His-93-->Gly.
    Barrick D
    Biochemistry; 1994 May; 33(21):6546-54. PubMed ID: 8204590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkylamine-ligated H93G myoglobin cavity mutant: a model system for endogenous lysine and terminal amine ligation in heme proteins such as nitrite reductase and cytochrome f.
    Du J; Perera R; Dawson JH
    Inorg Chem; 2011 Feb; 50(4):1242-9. PubMed ID: 21250678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilizing bound O2 in myoglobin by valine68 (E11) to asparagine substitution.
    Krzywda S; Murshudov GN; Brzozowski AM; Jaskolski M; Scott EE; Klizas SA; Gibson QH; Olson JS; Wilkinson AJ
    Biochemistry; 1998 Nov; 37(45):15896-907. PubMed ID: 9843395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.